Skip to main navigation Skip to search Skip to main content

Structure and biosynthetic implication of (S)-NHAB, a novel shunt product, from a disruptant of the actVI-ORFA gene for actinorhodin biosynthesis in Streptomyces coelicolor A3(2)

  • Makoto Ozawa
  • , Takaaki Taguchi
  • , Takayuki Itoh
  • , Yutaka Ebizuka
  • , Kevin I. Booker-Milburn
  • , G. Richard Stephenson
  • , Koji Ichinose

    Research output: Contribution to journalArticlepeer-review

    15 Citations (Scopus)

    Abstract

    A novel shunt product was isolated from a disruptant of the actVI-ORFA gene involved in the biosynthesis of actinorhodin (ACT) in Streptomyces coelicolor A3(2). Its structure was elucidated as 1,4-naphthoquinone-8-hydroxy-3-[3(S)-acetoxy-butyric acid], (S)-NHAB, based on NMR, MS. and CD spectroscopic data as well as a single crystal X-ray crystallographic analysis. The formation of (S)-NHAB involves a retro-Claisen type C-C bond cleavage of an ACT biosynthetic intermediate. Feeding experiments with [1-C-13] and [2-C-13] acetates indicated its biosynthetic origin as a single octaketide chain. The relevant gene product, Act-ORFA, which is a functionally unknown protein. is proposed to play a regulatory role related to the multi-enzymatic steps to ACT production, based on the metabolic profile of its disruptant and the wide distribution of actVI-ORFA homologues in the gene clusters for Streptomyces aromatic polyketides. (C) 2003 Elsevier Ltd. All rights reserved.
    Original languageEnglish
    Pages (from-to)8793-8798
    Number of pages6
    JournalTetrahedron
    Volume59
    Issue number44
    DOIs
    Publication statusPublished - 2003

    Cite this